• Journal of the Korean Society for Precision Engineering
• /
• v.33 no.5
• /
• pp.341-348
• /
• 2016

The solenoid valve is used widely across various industries; however, solenoid valves for use in high-temperature environments have to be highly specified, such as those used in thermal power plants and steel mills. As such, we have developed a solenoid valve, using an already developed solenoid, to allow for more specific use. In this type of development method, use of 3D printing is very effective, allowing for a reduction in errors in design and production. This study includes a mathematical model of the solenoid valve. Then, the simulation from the mathematical model was performed using the AMESim (Advanced Modeling Environment for Simulation of Engineering Systems). We made a prototype valve using the simulation results and also measured the flow rate and dynamic performance.

• Journal of Biosystems Engineering
• /
• v.31 no.1 s.114
• /
• pp.39-45
• /
• 2006

Fundamental informations on performance of sets of solenoid valve and nozzle were necessary to develop a target selectable spraying system. The experiments were performed for the sets of solenoid valves and flat spraying nozzles at 3 levels of the operating pressures, and the obtained results are as follows; Rise time of the system pressure to reach up to 90% of the operating pressure after the valve turned was affected by nozzle size and operating pressure. Maximum overshoot of the system pressure was about 170% not affected by the sets of valve and nozzle and operating pressure. The system pressure after its settle down within 5% of the set pressure showed good uniformity in any condition of the experiment as less as 2.3% of its coefficient of variation. Time requirement to lower the system pressure down to 50% after the valve power turned off was affected by valve and nozzle set and operating pressure.

• Journal of Chest Surgery
• /
• v.46 no.3
• /
• pp.208-211
• /
• 2013

A 51-year-old male was admitted to the hospital with complaints of fever and hemoptysis. After evaluation of the fever focus, he was diagnosed with pulmonary valve infective endocarditis. Thus pulmonary valve replacement and antibiotics therapy were performed and discharged. He was brought to the emergency unit presenting with a high fever (> $39^{\circ}C$) and general weakness 6 months after the initial operation. The echocardiography revealed prosthetic pulmonary valve endocarditis. Therefore, redo-pulmonary valve replacement using valved conduit was performed in the Rastelli fashion because of the risk of pulmonary arterial wall injury and recurrent endocarditis from the remnant inflammatory tissue. We report here on the successful surgical treatment of prosthetic pulmonary valve endocarditis with an alternative surgical method.

• Proceedings of the Korean Institute of Electrical and Electronic Material Engineers Conference
• /
• 2004.04b
• /
• pp.129-132
• /
• 2004

This paper describes the design, fabrication and characteristics of a piezoelectric valve using MCA(Multilayer ceramic actuator). The MCA valve, which has the buckling effect, consists of three separate structures; MCA, a valve actuator die and an a seat die. The design of the actuator die was done by FEM modeling and displacement measurement, respectively. The valve seat die with 6 trenches was made, and the actuator die, which is driven to MCA under optimized conditions, was also fabricated. After Si-wafer direct bonding between the seat die and the actuator die, MCA was also anodic bonded to the seat/actuator die structure. PDMS sealing pad was fabricated to minimize a leak-rate. It was also bonded to seat die and SUS package. The MCA valve shows a flow rate of 9.13 sccm at a supplied voltage of 100 V with a 50 % duty cycle, maximum non-linearity was 2.24 % FS and leak rate was $3.03{\times}10^{-8}\;pa{\cdot}m^3/cm^2$. Therefore, the fabricated MCA valve is suitable for a variety of flow control equipment, a medical bio-system, automobile and air transportation industry.

• Journal of Chest Surgery
• /
• v.26 no.1
• /
• pp.24-31
• /
• 1993

The long term clinical results following valve replacement with Hancock and Carpentier-Edwards bioprostheses were compared between tow valve models and between tow groups totaling 249 patients who were discharged after valve replacement from 1976 to 1986. The two groups of patients were treated with nonrandomized fashion. Follow-up was 87% complete. Cummulative duration of follow-up was 1909 patient-years, with maximum follow-up duration of 15 years. The actuarial survival for 122 patients with Hancock valves was 95.2%[\ulcornerstandard deviation] and 84.4% after 5 and 10 years of follow-up, respectively. Comparable figures for 127 patients undergoing valve replacement with Carpentier-Edwards valves were 87.3% and 76.4%, respectively[p=NS]. The probability of freedom from structural valve deterioration after 5 and 10 years of follow-up was 97.2% and 60.6%, respectively, with Hancock valves and 97.2% and 55.7%, respectively, with Carpentier-Edwards valves[p=NS]. Considering all 249 patients, multivariate [Cox model] regression revealed that ejection fraction was only significant predictor of structural valve deterioration. The probability of freedom from thromboembolism after 5 and 10 years of follow-up was 91.3% and 86.4%, respectively, with Hancock valves and 94.2% and 82.5%, respectively, with Carpentier-Edwards valves[p=NS]. Hence more strict control of anticoagulation should be done on patients with left atrial factors. In summary, there were no significant differences in actuarial survival rate and major valve related complications between tow valve models. These results suggests that its use should be confined to older patients or patients with a contraindication of anticoagulation.

• Journal of Chest Surgery
• /
• v.23 no.3
• /
• pp.488-500
• /
• 1990

Author compared the effect of surgical methods between 40 patients who received mitral valve replacement with complete excision of the mitral valve[resected group] and 41 patients who received mitral valve replacement with preservation of posterior chorda tendineae and posterior mitral leaflet[preserved group] from 1985. 2. to 1989. 4. at cardiothoracic department of Pusan National University Hospital.v 1. There was no significant difference between the preserved group and resected group in cardiopulmonary bypass time and aortic cross clamping time and NYHA classification. 2. In preserved group of Mitral stenosis and Mitral regurgitation, the left ventricular functions were much improved after mitral valve replacement than resected group, but there was not so difference between the preserved group and reserved group in Mitral steno-regurgitation. 3. There were remarkable decrease in complication rate in preserved group compared to resected group. And also the death rates were remarkably decreased in preserved group which was 4.9% compared to resected group which was 17.5%. As the preservation of the posterior mitral leaflet and chorda tendineae during mitral valve replacement in mitral valve disease showed significantly improved effects in the maintaining of left ventricular function and reducing the postoperative complication, I assume the preservation of posterior mitral leaflet and chordae during mitral valve replacement will bring better result.

• Journal of the Korea Academia-Industrial cooperation Society
• /
• v.10 no.3
• /
• pp.500-506
• /
• 2009

This study, is aimed to support the valve design engineer by a CAE simulation on the body of a PFA-lined plug valve, and focuses on static stress analysis, location of the weak point on bending and stiffness of the valve body. To determine whether the valve body can resist being transformed by loads, 1 simulated the stress distribution using CAD/CAE softwares. The 'step' file converted by CAD software after solid modeling is imported to the CAE software. Through simulation procedure, it is shown that the designed-solid-model fur a valve body has stiffness on bending and torsion but has weakness for side bending moment. Also, it is expected that the valve design engineer will understand the basic process of CAE and will be able to apply on his task.

• Journal of the Korean Society of Manufacturing Process Engineers
• /
• v.18 no.3
• /
• pp.109-115
• /
• 2019

The purpose of this study was to analyze and test the flow rate of a 1-inch ball valve used in a thermal power plant. To identify the flow-rate characteristics, numerical analysis was conducted and an experimental apparatus of the valve flow rate coefficient was used to compare the flow coefficient Cv values. To determine the internal pressure distribution, the sites of opening ball valves and flow fields were investigated. In particular, a smaller the valve opening resulted in a more complicated the flow field of the ball. The valve flow characteristic test showed that the Cv value and flow rate increased with increasing valve-opening rate and the secondary function was performed. The pressure drop increased as the valve opening rate decreased. In addition, the experimental results for the flow analysis are similar to the numerical analysis results.

• Journal of Chest Surgery
• /
• v.37 no.5
• /
• pp.401-409
• /
• 2004

Background: As the rupture of chordae and/or papillary muscle became the main cause of mitral valve regurgitation, mitral reconstructive surgery has a very important role. In this regard, we analyzed the clinical result and postoperative early result of operative treatment performed in our hospital, Material and Method: For this analysis, forty nine patients (male 26, female 23, mean age 49.0$\pm$16.5) who underwent mitral valve operation caused by the rupture of chordae and/or papillary muscle from August 1991 to April 2002 were reviewed. Among forty nine patients, twenty two (44.9%) received mital valve reconstruction and twenty seven (59.2%) received mitral valve replacement. Result: As to the pathological etiology of rupture of mitral and papillary muscle, twenty five cases (51.0%) were nonspecific degeneration, eleven cases (22.4%) were myxomatous degeneration, seven cases (14.3%) were subacute bacterial endocarditis. Three patients suffered mortality after operation (6.1%) and valve replacement was performed again on one patient because of remnant mitral insufficiency after valve reconstruction. The 5-year survival rate after operation for the entire mitral valve regurgitation patients was 81 .4%. We have also compared and analyzed the operation results of a group of patients who underwent valve reconstruction and the other group of patients who underwent valve replacement from thirty six patients who had suffered from mitral valve regurgitation caused by degenerative disease. The mortalities were 0% and 14.3%, respectively and the 5-year survival rates were 90.2% and 64.3%, respectively, but there were no statistical significance. Conclusion: The most common pathological etiology of mitral valve regurgitation caused by rupture of chordae and/or papillary muscle was nonspecific degeneration, In case of degenerative disease is the cause of mitral valve regurgitation, valve reconstruction showed better long-term effects in many respects and better operation results compared to valve replacement.

• Journal of Chest Surgery
• /
• v.20 no.3
• /
• pp.557-564
• /
• 1987

From September 1980 to July 1986, 135 cases of cardiac valve surgery were performed under the cardiopulmonary bypass. Out of 135 cases, single valve surgery was 114 cases including open mitral commissurotomy 17, mitral annuloplasty 2, mitral valve replacement 85, and aortic valve replacement 10 and double valve surgery was 21 cases. There were 68 males and 67 females ranging from 9 to 57 years of age. Early death within 30 days after operation was 17 cases [12.6%] and caused of death were ventricular arrhythmia 5, low cardiac output syndrome 4, excessive bleeding 3, pulmonary complication 2, and so on. Among 118 early survivors, 5 cases [5.1%] of late death were developed over a period of 2 to 72 months, and main cause of death was fatal bleeding complication associated with anticoagulation therapy. Symptomatically, 91.8% of patients were in NYHA functional class I or II at the end of the follow-up.